Polymun Scientific GmbH Report issue

For profit Phase 1
Founded: Klosterneuberg Austria (1992)
Status: No NME R&D (1992)

Organization Overview

First Clinical Trial
2005
NCT00264186
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2009

Timeline

NOW
  • Now

Alternative names

Polymun Scientific, Vienna, Austria

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Inflammation (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 2
  • # of Trial APIs: 6